br+/nad with tirzepatide GLP-1, NAD+ & Wellness Plans NAD + Tirzepatide: Safety &

A physician approved our treatment on June 5, and then we heard nothing in any channel until a shipping text arrived on June 22

They select a pharmacy for you, manage it behind the scenes, and the patient rarely sees the details

Contact your healthcare provider promptly for: Severe, persistent abdominal pain (potentially indicating pancreatitis) Signs of allergic reaction (rash, difficulty breathing, facial swelling) Symptoms of thyroid tumors (neck lump, hoarseness, difficulty swallowing) Severe hypoglycemia symptoms, especially if taking insulin or sulfonylureas Persistent vomiting or diarrhea that could lead to dehydration Vision changes (should be reported at your next appointment) Symptoms of gallbladder disease (right upper abdominal pain, fever, jaundice) Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use tirzepatide

If more than four days have passed, skip the missed dose and take the next one on schedule

The goal is to find one whose strengths align with your priorities and whose weaknesses are ones you can work around